OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1: expression regulation
Yujie Zhou, Guoli Li, Jiyin Wang, et al.
Blood Science (2023) Vol. 5, Iss. 2, pp. 77-91
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 17

Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression
Xuanxuan Wu, Zengjun Zhu, Jian Zhang, et al.
Clinical & Translational Oncology (2025)
Closed Access

PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Bing Yue, Yuxia Gao, Yi Hu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 5

ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling
Aziguli Tulamaiti, Shuyu Xiao, Yang Yan, et al.
Translational Oncology (2025) Vol. 52, pp. 102261-102261
Open Access

SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc
Zhe Qiao, Yu Li, Yao Cheng, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms
Han Han, Ting He, Yingfan Wu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3

p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
Ludovica Lopresti, Nagaja Capitani, Vanessa Tatangelo, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

New expression of PD-L1 on activated CD4+ T cells opens up new opportunities for cell interactions and signaling
Fabienne Mazerolles
Human Immunology (2024) Vol. 85, Iss. 4, pp. 110831-110831
Closed Access | Times Cited: 2

Cancer‐associated fibroblasts‐derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD‐L1
Huizhi Feng, Jingmei Liu, Haixia Jia, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 2

Association Between PD-L1 status Detected by SP142 and SP263 Antibody Clones and Clinical and Morphological Features of Gastric Cancer Factors
T. N. Sotnikova, T. V. Polushkina, Д. В. Калинин, et al.
Journal of Anatomy and Histopathology (2024) Vol. 12, Iss. 4, pp. 68-75
Open Access | Times Cited: 1

Molecular mechanism of specific HLA-A mRNA recognition by the RNA-binding-protein hMEX3B to promote tumor immune escape
Kanglong Yang, Guanglin Chen, Fan Yu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

PGM5-AS1 Promotes Progression of Diffuse Large B-Cell Lymphoma and Immune Escape by Regulating miR-503-5p
Xiaorong Qin, Hongyan Li, Jianqiu Wu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4187-4197
Open Access | Times Cited: 1

Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision
Tobias Kolb, Sarah Dorothea Müller, Peter Möller, et al.
Neoplasia (2024) Vol. 49, pp. 100955-100955
Open Access

Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC
Lu Wang, Ye He, Yijiang Bai, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access

Immunological features of EGFR-mutant non-small cell lung cancer and clinical practice: a narrative review
Yi Dong, L. Khan, Yi Yao
Journal of the National Cancer Center (2024) Vol. 4, Iss. 4, pp. 289-298
Open Access

Extracellular vesicles
Mariana Ottaiano Gonçalves, Juliana Fortes Di Iorio, Gabriela Villa Marin, et al.
Current topics in membranes (2024), pp. 1-31
Closed Access

Unraveling the complexity of Stenotrophomonas maltophilia – a comprehensive review of current knowledge
Bartosz Niemiec, Bruno Olesiński, Mateusz Szymański, et al.
Postępy Higieny i Medycyny Doświadczalnej (2024) Vol. 78, Iss. 1, pp. 103-110
Open Access

Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling
Victoria Ferrari, Baharia Mograbi, Jocelyn Gal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9991-9991
Open Access

In vivo edited eosinophils reconcile antigen specific Th2 response and mitigate airway allergy
Xiang‐Qian Luo, Jinna Yang, Haoyue Zheng, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access

Cuproptosis in Cancer Therapy: Mechanisms, Therapeutic Application and Future
Jiawei Hu, Junfei Zhu, Tao Chen, et al.
Journal of Materials Chemistry B (2024)
Closed Access

Page 1 - Next Page

Scroll to top